Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection—The Hawaii Aging with HIV Cohort

被引：0
|
作者：
Victor Valcour
Priscilla Yee
Andrew E. Williams
Bruce Shiramizu
Michael Watters
Ola Selnes
Robert Paul
Cecilia Shikuma
Ned Sacktor
机构：
[1] University of Hawaii,Hawaii AIDS Clinical Research Program
[2] University of Hawaii,John A. Burns School of Medicine
[3] Johns Hopkins University School of Medicine,Department of Psychology, Division of Behavioral Neuroscience
[4] University of Missouri,Office of Neurology and Aging Research, Sinclair 202
[5] Leahi Hospital,undefined
来源：
Journal of NeuroVirology | 2006年 / 12卷
关键词：
AIDS dementia complex; CD4 lymphocyte count; polyneuropathies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Low CD4 lymphocyte count was a marker for neurological disease in human immunodeficiency virus type 1 (HIV-1); but is now less common among patients with access to highly active antiretroviral therapy. In this study, the authors determine the reliability of self-reported CD4 nadir and its predictive value for neurological status. The authors identify a high degree of reliability (r = .90). After adjusting for age, current CD4 count, and duration of HIV-1, CD4 nadir relates to a current diagnosis of HIV-associated dimentia (HAD) (odds ratio [OR]: 1.395 (1.106–1.761), P = .005) and distal symmetric polyneuropathy (DSPN) (OR: 1.479 (1.221–1.769, P < .001).
引用
收藏
页码：387 / 391
页数：4
相关论文
共 50 条
  • [21] Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era
    Ronald A. Cohen
    Jaroslaw Harezlak
    Giovanni Schifitto
    George Hana
    Uraina Clark
    Assawin Gongvatana
    Robert Paul
    Michael Taylor
    Paul Thompson
    Jeffery Alger
    Mark Brown
    Jianhui Zhong
    Thomas Campbell
    Elyse Singer
    Eric Daar
    Deborah McMahon
    Yuen Tso
    Constantin T. Yiannoutsos
    Bradford Navia
    Journal of NeuroVirology, 2010, 16 : 25 - 32
  • [22] Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era
    Cohen, Ronald A.
    Harezlak, Jaroslaw
    Schifitto, Giovanni
    Hana, George
    Clark, Uraina
    Gongvatana, Assawin
    Paul, Robert
    Taylor, Michael
    Thompson, Paul
    Alger, Jeffery
    Brown, Mark
    Zhong, Jianhui
    Campbell, Thomas
    Singer, Elyse
    Daar, Eric
    McMahon, Deborah
    Tso, Yuen
    Yiannoutsos, Constantin T.
    Navia, Bradford
    JOURNAL OF NEUROVIROLOGY, 2010, 16 (01) : 25 - 32
  • [23] ROLE OF CD4 ENDOCYTOSIS IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    PELCHENMATTHEWS, A
    CLAPHAM, P
    MARSH, M
    JOURNAL OF VIROLOGY, 1995, 69 (12) : 8164 - 8168
  • [24] Incomplete Recovery of CD4 Cell Count, CD4 Percentage, and CD4/CD8 Ratio in Patients With Human Immunodeficiency Virus Infection and Suppressed Viremia During Long-term Antiretroviral Therapy
    Mutoh, Yoshikazu
    Nishijima, Takeshi
    Inaba, Yosuke
    Tanaka, Noriko
    Kikuchi, Yoshimi
    Gatanaga, Hiroyuki
    Oka, Shinichi
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (06) : 927 - 933
  • [25] Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4
    Volsky, DJ
    Simm, M
    Shahabuddin, M
    Li, GR
    Chao, W
    Potash, MJ
    JOURNAL OF VIROLOGY, 1996, 70 (06) : 3823 - 3833
  • [26] Engineering a CD4 mimetic inhibiting the binding of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein gp120 to human lymphocyte CD4 by the transfer of a CD4 functional site to a small natural scaffold
    Eugenia Drakopoulou
    Jean Vizzavona
    Claudio Vita
    Letters in Peptide Science, 1998, 5 : 241 - 245
  • [27] Engineering a CD4 mimetic inhibiting the binding of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein gp120 to human lymphocyte CD4 by the transfer of a CD4 functional site to a small natural scaffold
    Drakopoulou, E
    Vizzavona, J
    Vita, C
    LETTERS IN PEPTIDE SCIENCE, 1998, 5 (2-3): : 241 - 245
  • [28] Engineering a CD4 mimetic inhibiting the binding of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein gp120 to human lymphocyte CD4 by the transfer of a CD4 functional site to a small natural scaffold
    Eugenia Drakopoulou
    Jean Vizzavona
    Claudio Vita
    Letters in Peptide Science, 1998, 5 : 241 - 245
  • [29] Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya
    Land, Allison M.
    Ball, T. Blake
    Luo, Ma
    Pilon, Richard
    Sandstrom, Paul
    Embree', Joanne E.
    Wachihi, Charles
    Kimani, Joshua
    Plummer, Francis A.
    JOURNAL OF VIROLOGY, 2008, 82 (16) : 8172 - 8182
  • [30] CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus load
    Miller, V
    Staszewski, S
    Sabin, C
    Carlebach, A
    Rottmann, C
    Weidmann, E
    Rabenau, H
    Hill, A
    Lepri, AC
    Phillips, AN
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02): : 530 - 533
12345